Different patterns of relapse after autologous peripheral blood stem cell transplantation in multiple myeloma: clinical results of 280 cases from the Spanish Registry
Adrían Alegre(Hospital Universitario de La Princesa), Jesús F. San Miguel(Clinica Universidad de Navarra), Javier de la Rubia(Universitat de València), Rafael Martínez(Hospital Clínico San Carlos), Anna Sureda(Institut d'Investigació Biomédica de Bellvitge), Juan José Lahuerta(Research Institute Hospital 12 de Octubre), A Granda(Unknown), Joan Bladé(Hospital Clínic de Barcelona)
Cited by 90
Related Papers
International Staging System for Multiple Myeloma
|Journal of Clinical Oncology|2005|2.9k
International uniform response criteria for multiple myeloma
|Leukemia|2006|2.6k
Revised International Staging System for Multiple Myeloma: A Report From International Myeloma Working Group
|Journal of Clinical Oncology|2015|2.2k
Axicabtagene Ciloleucel as Second-Line Therapy for Large B-Cell Lymphoma
|New England Journal of Medicine|2021|1.6k
CRITERIA FOR EVALUATING DISEASE RESPONSE AND PROGRESSION IN PATIENTS WITH MULTIPLE MYELOMA TREATED BY HIGH‐DOSE THERAPY AND HAEMOPOIETIC STEM CELL TRANSPLANTATION
|British Journal of Haematology|1998|1.5k